KIRK GAUTIER: Open Payments
NPI 1821027798 · ATHENS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98,121 in 309 payments from 18 companies in 2025. Trend: 2023 $76,098 · 2024 $140,139 · 2025 $98,121
Speaker / faculty: $77,492Consulting: $8,303Travel & lodging: $7,000Food & beverage: $4,941Education: $385
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 82 | $41,754 |
| Lilly USA, LLC | 57 | $30,613 |
| ABBVIE INC. | 55 | $17,725 |
| Arcutis Biotherapeutics, Inc. | 11 | $4,554 |
| Regeneron Healthcare Solutions, Inc. | 25 | $790 |
| GENZYME CORPORATION | 18 | $550 |
| LEO Pharma Inc. | 6 | $365 |
| Kowa Pharmaceuticals America, Inc. | 1 | $350 |
| Galderma Laboratories, L.P. | 14 | $327 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $233 |
Products named: Bimzelx, EBGLYSS, RINVOQ, SKYRIZI, Zoryve, DUPIXENT, NEMLUVIO, LIBTAYO.
Industry payments across TX — which companies pay providers there.
